Ahlijanian M[au] - Search Results

Year	Number of Results
1985	1
1986	5
1987	3
1988	3
1990	2
1991	1
1992	1
1993	1
1997	1
1998	1
2000	1
2003	4
2004	1
2009	1
2011	2
2012	1
2013	2
2014	5
2015	2
2016	7
2017	5
2018	2
2019	2
2020	2
2022	0

1

Interpreting Alzheimer's disease clinical trials in light of the effects on amyloid-β.

Toyn JH, Ahlijanian MK. Toyn JH, et al. Among authors: ahlijanian mk. Alzheimers Res Ther. 2014 Mar 12;6(2):14. doi: 10.1186/alzrt244. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25031632 Free PMC article. Review.

2

USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation.

Rusilowicz-Jones EV, Jardine J, Kallinos A, Pinto-Fernandez A, Guenther F, Giurrandino M, Barone FG, McCarron K, Burke CJ, Murad A, Martinez A, Marcassa E, Gersch M, Buckmelter AJ, Kayser-Bricker KJ, Lamoliatte F, Gajbhiye A, Davis S, Scott HC, Murphy E, England K, Mortiboys H, Komander D, Trost M, Kessler BM, Ioannidis S, Ahlijanian MK, Urbé S, Clague MJ. Rusilowicz-Jones EV, et al. Among authors: ahlijanian mk. Life Sci Alliance. 2020 Jul 7;3(8):e202000768. doi: 10.26508/lsa.202000768. Print 2020 Aug. Life Sci Alliance. 2020. PMID: 32636217 Free PMC article.

3

Synthesis of functionalized derivatives of the gamma-secretase modulator BMS-932481 and identification of its major metabolite.

Zhang Y, Boy KM, Wu YJ, Ramirez A, Toyn JH, Ahlijanian MK, Albright CF, Zhuo X, Johnson BM, Denton RR, Olson RE, Thompson LA 3rd, Macor JE. Zhang Y, et al. Among authors: ahlijanian mk. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127530. doi: 10.1016/j.bmcl.2020.127530. Epub 2020 Sep 2. Bioorg Med Chem Lett. 2020. PMID: 32890687

4

Role of cdk5 in the pathogenesis of Alzheimer's disease.

Lau LF, Ahlijanian MK. Lau LF, et al. Among authors: ahlijanian mk. Neurosignals. 2003 Sep-Oct;12(4-5):209-14. doi: 10.1159/000074622. Neurosignals. 2003. PMID: 14673207 Review.

5

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481.

Boy KM, Guernon JM, Zuev DS, Xu L, Zhang Y, Shi J, Marcin LR, Higgins MA, Wu YJ, Krishnananthan S, Li J, Trehan A, Smith D, Toyn JH, Meredith JE, Burton CR, Kimura SR, Zvyaga T, Zhuo X, Lentz KA, Grace JE, Denton R, Morrison JS, Mathur A, Albright CF, Ahlijanian MK, Olson RE, Thompson LA, Macor JE. Boy KM, et al. Among authors: ahlijanian mk. ACS Med Chem Lett. 2019 Feb 17;10(3):312-317. doi: 10.1021/acsmedchemlett.8b00541. eCollection 2019 Mar 14. ACS Med Chem Lett. 2019. PMID: 30891132 Free PMC article.

6

Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry.

Huang RY, Iacob RE, Sankaranarayanan S, Yang L, Ahlijanian M, Tao L, Tymiak AA, Chen G. Huang RY, et al. Among authors: ahlijanian m. J Am Soc Mass Spectrom. 2018 Jan;29(1):174-182. doi: 10.1007/s13361-017-1815-8. Epub 2017 Oct 2. J Am Soc Mass Spectrom. 2018. PMID: 28971440

7

Synergistic inhibition of Aβ production by combinations of γ-secretase modulators.

Robertson AS, Iben LG, Wei C, Meredith JE Jr, Drexler DM, Banks M, Vite GD, Olson RE, Thompson LA, Albright CF, Ahlijanian MK, Toyn JH. Robertson AS, et al. Among authors: ahlijanian mk. Eur J Pharmacol. 2017 Oct 5;812:104-112. doi: 10.1016/j.ejphar.2017.07.019. Epub 2017 Jul 8. Eur J Pharmacol. 2017. PMID: 28690193

8

A randomized, single ascending dose study of intravenous BIIB092 in healthy participants.

Qureshi IA, Tirucherai G, Ahlijanian MK, Kolaitis G, Bechtold C, Grundman M. Qureshi IA, et al. Among authors: ahlijanian mk. Alzheimers Dement (N Y). 2018 Dec 17;4:746-755. doi: 10.1016/j.trci.2018.10.007. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30581980 Free PMC article.

9

A Functional Na_V1.7-Na_VAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site.

Rajamani R, Wu S, Rodrigo I, Gao M, Low S, Megson L, Wensel D, Pieschl RL, Post-Munson DJ, Watson J, Langley DR, Ahlijanian MK, Bristow LJ, Herrington J. Rajamani R, et al. Among authors: ahlijanian mk. Mol Pharmacol. 2017 Sep;92(3):310-317. doi: 10.1124/mol.117.108712. Epub 2017 Jun 23. Mol Pharmacol. 2017. PMID: 28645932

10

B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor.

Post-Munson DJ, Pieschl RL, Molski TF, Graef JD, Hendricson AW, Knox RJ, McDonald IM, Olson RE, Macor JE, Weed MR, Bristow LJ, Kiss L, Ahlijanian MK, Herrington J. Post-Munson DJ, et al. Among authors: ahlijanian mk. Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037. Epub 2017 Jan 26. Eur J Pharmacol. 2017. PMID: 28132910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results